Michael Siu

10PUBLICATIONS
32CO-AUTHORS
Molecular targetsNeural engineeringImmunogenetics (incl. genetic immunology)Toxicology (incl. clinical toxicology)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 02, 2026
Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C.

Matthew L Landry, Sushant Malhotra, Maureen Beresini

|Sep 18, 2024
Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1.

John C Tellis, BinQing Wei, Michael Siu

|Nov 15, 2021
Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors.

Dennis X Hu, Snahel Patel, Huifen Chen

|May 31, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor.

Malcolm P Huestis, Matthew R Durk, Charles Eigenbrot

|Mar 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3H)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor.

Malcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale

Pageof 2